Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
FGFR3 signaling and function in triple negative breast cancer
Nicole J. Chew et al.
CELL COMMUNICATION AND SIGNALING (2020)
HER2-positive advanced breast cancer treatment in 2020
Marcelle G. Cesca et al.
CANCER TREATMENT REVIEWS (2020)
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets
Rosamaria Lappano et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
Navid Sobhani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
Jamie R. Kutasovic et al.
CANCERS (2020)
Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches
Harman Saman et al.
CANCERS (2020)
Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions
Agnieszka Dominiak et al.
CANCERS (2020)
FGFR4: A promising therapeutic target for breast cancer and other solid tumors
Kevin M. Levine et al.
PHARMACOLOGY & THERAPEUTICS (2020)
TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway
Jingjing Qiao et al.
BIOCHEMICAL GENETICS (2020)
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?
Essia Mezni et al.
CANCERS (2020)
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival
Chantal Bourrier et al.
CANCERS (2020)
Circulating Tumor Cells in Metastatic Breast Cancer: From Genome Instability to Metastasis
Ekaterina Ivanova et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling
Jinyoung Suh et al.
MOLECULAR CARCINOGENESIS (2020)
FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients
Ning Xie et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Sprouty2a Novel Therapeutic Target in the Nervous System?
Barbara Hausott et al.
MOLECULAR NEUROBIOLOGY (2019)
Liquid biopsy in breast cancer: A comprehensive review
Sahar Alimirzaie et al.
CLINICAL GENETICS (2019)
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER plus breast cancer
Luigi Formisano et al.
NATURE COMMUNICATIONS (2019)
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression
Maria Francesca Santolla et al.
CELLS (2019)
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer
Dominika Piasecka et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
Marta Latko et al.
CELLS (2019)
PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B
Praveen-Kumar Raj-Kumar et al.
SCIENTIFIC REPORTS (2019)
A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment
Jinho Kang et al.
SCIENTIFIC REPORTS (2019)
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai et al.
CELLS (2019)
Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells
Burcu Emine Celik-Selvi et al.
CELLS (2019)
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
Jinglin Zhang et al.
CELLS (2019)
Fibroblast Growth Factor Receptor Signaling in Skin Cancers
Malgorzata Czyz
CELLS (2019)
Fibroblast Growth Factor Receptor Functions in Glioblastoma
Ana Jimenez-Pascual et al.
CELLS (2019)
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
Xia Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cancer-associated adipocytes: key players in breast cancer progression
Qi Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Immune Microenvironment of Breast Cancer Progression
Helen Tower et al.
CANCERS (2019)
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
David M. Hyman et al.
JCO PRECISION ONCOLOGY (2019)
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
Jiani Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
Junqiang Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs)
Rosamaria Lappano et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Kaixuan Wang et al.
ONCOGENE (2018)
Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer
Kristina Golfmann et al.
ONCOGENE (2018)
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Aurelie S. Cazet et al.
NATURE COMMUNICATIONS (2018)
The LIS1/NDE1 Complex Is Essential for FGF Signaling by Regulating FGF Receptor Intracellular Trafficking
Liansheng Liu et al.
CELL REPORTS (2018)
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
Navid Sobhani et al.
CELLS (2018)
Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling
Sangwon Lee et al.
NATURE (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel based chemotherapy in breast cancer patients
Lu Chen et al.
BMC CANCER (2018)
The Yin and Yang of Myeloid Derived Suppressor Cells
Snehil Budhwar et al.
FRONTIERS IN IMMUNOLOGY (2018)
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation
Elizabeth A. Wellberg et al.
JCI INSIGHT (2018)
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogova et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
Lukasz Turczyk et al.
NEOPLASIA (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer
Luigi Formisano et al.
CLINICAL CANCER RESEARCH (2017)
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
J. H. Chung et al.
ANNALS OF ONCOLOGY (2017)
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2
Ariella B. Hanker et al.
CLINICAL CANCER RESEARCH (2017)
Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment
N. S. Clayton et al.
DEVELOPMENTAL DYNAMICS (2017)
Advances and challenges in targeting FGFR signalling in cancer
Irina S. Babina et al.
NATURE REVIEWS CANCER (2017)
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy
Antonino Musolino et al.
BREAST CANCER RESEARCH (2017)
A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors
A. W. Tolcher et al.
ANNALS OF ONCOLOGY (2016)
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten et al.
CLINICAL CANCER RESEARCH (2016)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Yu-Jie Shi et al.
ONCOTARGET (2016)
Phase 1 study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours
J. Rodon et al.
ANNALS OF ONCOLOGY (2016)
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
D. Fumagalli et al.
ANNALS OF ONCOLOGY (2016)
Discovering and understanding oncogenic gene fusions through data intensive computational approaches
Natasha S. Latysheva et al.
NUCLEIC ACIDS RESEARCH (2016)
Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy
Arianna Giacomini et al.
PHARMACOLOGICAL RESEARCH (2016)
Dysregulated FGF signalling in neoplastic disorders
Yasmine Tanner et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
Dominika Piasecka et al.
ONCOTARGET (2016)
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
James Campbell et al.
CELL REPORTS (2016)
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
Celine Lefebvre et al.
PLOS MEDICINE (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
Fabrice Andre et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics
A. Parish et al.
CELL CYCLE (2015)
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer
Chuanbing Zang et al.
CELL CYCLE (2015)
Fibroblast Growth Factor Signaling in the Vasculature
Xuehui Yang et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site
Vijay K. Ulaganathan et al.
NATURE (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Kazuyoshi Shiga et al.
CANCERS (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer
Xue B. Holdman et al.
BREAST CANCER RESEARCH (2015)
Phase II multicenter proof of concept study of AZD4547 in FGFR amplified tumours.
Elizabeth Catherine Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2014)
Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
FPA144: A therapeutic antibody for treating patients with gastric cancers bearing FGFR2 gene amplification
Abigael T. Gemo et al.
CANCER RESEARCH (2014)
Reductions in Myeloid-Derived Suppressor Cells and Lung Metastases using AZD4547 Treatment of a Metastatic Murine Breast Tumor Model
Li Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis
Xiaohong Zhang et al.
DEVELOPMENT (2014)
Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis
Sunday S. Oladipupo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4
Julie A. Tucker et al.
STRUCTURE (2014)
Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2013)
Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study
Shaneda Warren Andersen et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
Fibroblast Growth Factor Receptor Signaling Is Essential for Normal Mammary Gland Development and Stem Cell Function
Adam C. Pond et al.
STEM CELLS (2013)
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu et al.
CANCER DISCOVERY (2013)
The FGF/FGF receptor axis as a therapeutic target in breast cancer
Nicholas J. Brady et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2013)
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models
Amine Issa et al.
BREAST CANCER RESEARCH (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
A Phase I Dose-escalation Study of MFGR1877S, a Human Monoclonal Anti-fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients (pts) with Advanced Solid Tumors
P. ODonnell et al.
EUROPEAN JOURNAL OF CANCER (2012)
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Matthew J. Potthoff et al.
GENES & DEVELOPMENT (2012)
Mechanisms of FGFR3 actions in endocrine resistant breast cancer
D. C. Tomlinson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Increased Expression of Fibroblastic Growth Factor Receptor 2 Is Correlated With Poor Prognosis in Patients With Breast Cancer
Shanshan Sun et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Macrophages Promote Fibroblast Growth Factor Receptor-Driven Tumor Cell Migration and Invasion in a Cxcr2-Dependent Manner
Laura R. Bohrer et al.
MOLECULAR CANCER RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner
Johanna R. Reed et al.
PLOS ONE (2012)
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure
Koichi Azuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Juan P. Cerliani et al.
CANCER RESEARCH (2011)
Biology of FGFRL1, the fifth fibroblast growth factor receptor
Beat Trueb
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
Rachel Sharpe et al.
CLINICAL CANCER RESEARCH (2011)
Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
Christopher Lieu et al.
CLINICAL CANCER RESEARCH (2011)
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor
Elisa Frullanti et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2011)
rs2981582 is associated with FGFR2 expression in normal breast
Chang Sun et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Potential for Targeting the Fibroblast Growth Factor Receptors in Breast Cancer
Nancy E. Hynes et al.
CANCER RESEARCH (2010)
GP369, an FGFR2-IIIb-Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling
Ailin Bai et al.
CANCER RESEARCH (2010)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Ellen Margrethe Haugsten et al.
MOLECULAR CANCER RESEARCH (2010)
Histological types of breast cancer: How special are they?
Britta Weigelt et al.
MOLECULAR ONCOLOGY (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
De-regulated FGF receptors as therapeutic targets in cancer
Victoria Knights et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Laureen S. Ojalvo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
FGFR2 Abnormalities Underlie a Spectrum of Bone, Skin, and Cancer Pathologies
Masaru Katoh
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Michael G. Gartside et al.
MOLECULAR CANCER RESEARCH (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis
S. S. Kwek et al.
ONCOGENE (2009)
Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase
Junji Matsui et al.
CLINICAL CANCER RESEARCH (2008)
Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling
Sara Parsa et al.
DEVELOPMENTAL BIOLOGY (2008)
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
Danielle Meijer et al.
ENDOCRINE-RELATED CANCER (2008)
Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
Sebastian Giulianelli et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer
Kerstin B. Meyer et al.
PLOS BIOLOGY (2008)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J. Hunter et al.
NATURE GENETICS (2007)
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
Richard Grose et al.
EMBO JOURNAL (2007)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
Sef is a feed back-induced antagonist of Ras/MAPK-mediated FGF signalling
M Fürthauer et al.
NATURE CELL BIOLOGY (2002)
Share Paper
